Medical Injectable Drug Program Changes in the New Year
Summary
Effective January 1, 2027, Highmark is adding 13 new drugs to its Medical Injectable Drug Program and adjusting reimbursement rates to align with average selling price (ASP) or average wholesale price (AWP) for drugs lacking an ASP. These drugs receive HCPCS codes and remain in the program once coded. Billing teams must update their systems to recognize these new HCPCS codes and apply the correct reimbursement methodology.
Get alerts when payers change rules like this one
We check Highmark and other payers every day and email you when a change matches your specialty and state.